Two studies find role for alternative lengthening of telomeres in treatment-resistant tumors

by

Two recent papers from researchers in the Children’s Hospital of Philadelphia (CHOP) Cancer Center have advanced the understanding of treatment-resistant pediatric tumors, both in assessing a novel treatment and in characterizing the role of alternative lengthening of telomeres (ALT) in these refractory tumors.

Leave A Comment

Your email address will not be published. Required fields are marked *